These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2506950

  • 21. Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-beta 1 genes in breast tumour cells.
    Nutt JE, Harris AL, Lunec J.
    Br J Cancer; 1991 Oct; 64(4):671-6. PubMed ID: 1911215
    [Abstract] [Full Text] [Related]

  • 22. Different effects of the two protein kinase C activators bryostatin-1 and TPA on growth and differentiation of human monocytic leukemia cell lines.
    Steube KG, Grunicke D, Quentmeier H, Drexler HG.
    Leuk Res; 1993 Oct; 17(10):897-901. PubMed ID: 8412301
    [Abstract] [Full Text] [Related]

  • 23. Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia.
    Kitada S, Zapata JM, Andreeff M, Reed JC.
    Br J Haematol; 1999 Sep; 106(4):995-1004. PubMed ID: 10520003
    [Abstract] [Full Text] [Related]

  • 24. Phorbol ester and B cell-stimulatory factor synergize to induce B-chronic lymphocytic leukemia cells to simultaneous immunoglobulin secretion and DNA synthesis.
    Carlsson M, Matsson P, Rosén A, Sundström C, Tötterman TH, Nilsson K.
    Leukemia; 1988 Nov; 2(11):734-44. PubMed ID: 3263557
    [Abstract] [Full Text] [Related]

  • 25. Bryostatin 1-induced modulation of the acute lymphoblastic leukemia cell line Reh.
    al-Katib A, Mohammad RM, Khan K, Dan ME, Pettit GR, Sensenbrenner LL.
    J Immunother Emphasis Tumor Immunol; 1993 Jul; 14(1):33-42. PubMed ID: 8399068
    [Abstract] [Full Text] [Related]

  • 26. Potentiation of 2-chlorodeoxyadenosine activity by bryostatin 1 in the resistant chronic lymphocytic leukemia cell line (WSU-CLL): association with increased ratios of dCK/5'-NT and Bax/Bcl-2.
    Mohammad RM, Beck FW, Katato K, Hamdy N, Wall N, Al-Katib A.
    Biol Chem; 1998 Oct; 379(10):1253-61. PubMed ID: 9820586
    [Abstract] [Full Text] [Related]

  • 27. Different biological effects of the two protein kinase C activators bryostatin-1 and TPA on human carcinoma cell lines.
    Steube KG, Grunicke D, Drexler HG.
    Invest New Drugs; 1994 Oct; 12(1):15-23. PubMed ID: 7960600
    [Abstract] [Full Text] [Related]

  • 28. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells.
    Stanwell C, Gescher A, Bradshaw TD, Pettit GR.
    Int J Cancer; 1994 Feb 15; 56(4):585-92. PubMed ID: 8112895
    [Abstract] [Full Text] [Related]

  • 29. Protein kinase C-alpha but not protein kinase C-epsilon is differentially down-regulated by bryostatin 1 and tetradecanoyl phorbol 13-acetate in SH-SY5Y human neuroblastoma cells.
    Jalava A, Lintunen M, Heikkilä J.
    Biochem Biophys Res Commun; 1993 Mar 15; 191(2):472-8. PubMed ID: 8461005
    [Abstract] [Full Text] [Related]

  • 30. 1alpha,25-dihydroxyvitamin D3 and bryostatin-1 synergize to induce monocytic differentiation of NB4 acute promyelocytic leukemia cells by modulating cell cycle progression.
    Clark CS, Konyer JE, Meckling KA.
    Exp Cell Res; 2004 Mar 10; 294(1):301-11. PubMed ID: 14980523
    [Abstract] [Full Text] [Related]

  • 31. Analysis of signal transduction in B chronic lymphocytic leukemia cells.
    Drexler HG, Brenner MK, Coustan-Smith E, Gignac SM, Hoffbrand AV.
    Blood; 1988 May 10; 71(5):1461-9. PubMed ID: 3129049
    [Abstract] [Full Text] [Related]

  • 32. Phorbol ester-stimulated phosphorylation of PU.1: association with leukemic cell growth inhibition.
    Carey JO, Posekany KJ, deVente JE, Pettit GR, Ways DK.
    Blood; 1996 May 15; 87(10):4316-24. PubMed ID: 8639791
    [Abstract] [Full Text] [Related]

  • 33. Effect of AS101 on bryostatin 1-mediated differentiation induction, cell cycle arrest, and modulation of drug-induced apoptosis in human myeloid leukemia cells.
    Rao AS, Freemerman AJ, Jarvis WD, Chelliah J, Bear HD, Mikkelsen R, Grant S.
    Leukemia; 1996 Jul 15; 10(7):1150-8. PubMed ID: 8683995
    [Abstract] [Full Text] [Related]

  • 34. Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1.
    Mohammad RM, Varterasian ML, Almatchy VP, Hannoudi GN, Pettit GR, Al-Katib A.
    Clin Cancer Res; 1998 May 15; 4(5):1337-43. PubMed ID: 9607595
    [Abstract] [Full Text] [Related]

  • 35. Bryostatin 1 antagonizes the terminal differentiating action of 12-O-tetradecanoylphorbol-13-acetate in a human colon cancer cell.
    McBain JA, Pettit GR, Mueller GC.
    Carcinogenesis; 1988 Jan 15; 9(1):123-9. PubMed ID: 3335036
    [Abstract] [Full Text] [Related]

  • 36. Varied differentiation responses of human leukemias to bryostatin 1.
    Kraft AS, William F, Pettit GR, Lilly MB.
    Cancer Res; 1989 Mar 01; 49(5):1287-93. PubMed ID: 2917358
    [Abstract] [Full Text] [Related]

  • 37. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
    Jalava A, Akerman K, Heikkilä J.
    J Cell Physiol; 1993 May 01; 155(2):301-12. PubMed ID: 8482723
    [Abstract] [Full Text] [Related]

  • 38. The differentiation inducing effect of bryostatin 5 on human myeloid blast cells is potentiated by vitamin D3.
    van der Hem KG, Dräger AM, Huijgens PC, Tol C, Devillé W, Langenhuijsen MM.
    Leukemia; 1994 Feb 01; 8(2):266-73. PubMed ID: 7508534
    [Abstract] [Full Text] [Related]

  • 39. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
    Grant S, Turner AJ, Freemerman AJ, Wang Z, Kramer L, Jarvis WD.
    Exp Cell Res; 1996 Oct 10; 228(1):65-75. PubMed ID: 8892972
    [Abstract] [Full Text] [Related]

  • 40. Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitro.
    Jones RJ, Sharkis SJ, Miller CB, Rowinsky EK, Burke PJ, May WS.
    Blood; 1990 Mar 15; 75(6):1319-23. PubMed ID: 2310830
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.